Catalyst Wire Dossier Catalyst Wire Dossier

linagliptin/metformin fixed-dose combination

linagliptin/metformin · Boehringer Ingelheim / Eli Lilly
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for linagliptin/metformin fixed-dose combination, covering 2013-08-06 to 2014-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets [Phase 1]

See pricing